Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data to Pocket $12M in Private Stock Placement

NEW YORK, Nov. 18 (GenomeWeb News) - Clinical Data has signed agreements with investors for a $12-million private placement of its common stock, the company said today.


The investors will purchase 614,629 shares of newly issued common stock and receive warrants to purchase 307,315 shares of additional common stock, for a total price of $12.025 million.


The "certain institutional and other accredited investors" remain unnamed at this time.


Clinical Data said it will use the gross proceeds from the placement to pay down outstanding indebtedness and to support its growth plans as it integrates Genaissance's operations and Icoria.


The company expects to close the Icoria acquisition in mid-December.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.